Skip to Content

Virtual drug trials will let you join a test from the comfort of your own home

August 30, 2018

Stay-at-home trials are allowing more people to participate in test runs.

The past: Participants in drug trials previously had to spend a lot of time and money visiting research locations. That hassle contributes to a 30 percent dropout rate.

The future: Virtual trials have people do the work and testing themselves. “Because we bring trials to patients in their homes, we remove barriers, whether geography or time and inconvenience, that are preventing them from participating,” Belinda Tan, cofounder of Science 37, told Undark. A recent trial by AOBiome Therapeutics of an acne medication recruited people through social media, screened 8,000 candidates online, and conducted the research through traditional mail, e-mail, iPhone app, and videoconferencing.

Ups and downs: While virtual trials are cheaper and more convenient, it does make it harder to ensure that some tests are done consistently and properly, since many people don’t like injecting themselves.

This story first appeared in our daily tech newsletter, The Download. You can sign up here.

Deep Dive


These scientists used CRISPR to put an alligator gene into catfish

The resulting fish appear to be more resistant to disease and could improve commercial production—should they ever be approved.

Next up for CRISPR: Gene editing for the masses?

Last year, Verve Therapeutics started the first human trial of a CRISPR treatment that could benefit most people—a signal that gene editing may be ready to go mainstream.

CRISPR for high cholesterol: 10 Breakthrough Technologies 2023

New forms of the gene-editing tool could enable treatments for common diseases.

An ALS patient set a record for communicating via a brain implant: 62 words per minute

Brain interfaces could let paralyzed people speak at almost normal speeds.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at with a list of newsletters you’d like to receive.